| 000 | 01565 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250515110431.0 | ||
| 264 | 0 | _c20080710 | |
| 008 | 200807s 0 0 eng d | ||
| 022 | _a1463-1326 | ||
| 024 | 7 |
_a10.1111/j.1463-1326.2007.00826.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKhutsoane, D | |
| 245 | 0 | 0 |
_aBiphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: experience from the PRESENT study. _h[electronic resource] |
| 260 |
_bDiabetes, obesity & metabolism _cMar 2008 |
||
| 300 |
_a212-22 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aBiphasic Insulins |
| 650 | 0 | 4 |
_aBlood Glucose _xmetabolism |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xblood |
| 650 | 0 | 4 | _aFamily Practice |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemia _xmetabolism |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aInsulin _xanalogs & derivatives |
| 650 | 0 | 4 | _aInsulin Aspart |
| 650 | 0 | 4 | _aInsulin, Isophane |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aSharma, S K | |
| 700 | 1 | _aAlmustafa, M | |
| 700 | 1 | _aJang, H C | |
| 700 | 1 | _aAzar, S T | |
| 700 | 1 | _aDanciulescu, R | |
| 700 | 1 | _aShestakova, M | |
| 700 | 1 | _aAyad, N M A | |
| 700 | 1 | _aGuler, S | |
| 700 | 1 | _aBech, O M | |
| 773 | 0 |
_tDiabetes, obesity & metabolism _gvol. 10 _gno. 3 _gp. 212-22 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1463-1326.2007.00826.x _zAvailable from publisher's website |
| 999 |
_c17774702 _d17774702 |
||